Cargando…

Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic Study

Background: Tuberculosis (TB) patients admitted to intensive care units (ICU) have high mortality rates. It is uncertain whether the pharmacokinetics of first-line TB drugs in ICU patients are different from outpatients. This study aims to compare the pharmacokinetics of oral ethambutol in TB patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beraldi-Magalhaes, Francisco, Parker, Suzanne L., Sanches, Cristina, Sousa Garcia, Leandro, Souza Carvalho, Brenda Karoline, Fachi, Mariana Millan, de Liz, Marcus Vinicius, Pontarolo, Roberto, Lipman, Jeffrey, Cordeiro-Santos, Marcelo, Roberts, Jason A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698281/ https://www.ncbi.nlm.nih.gov/pubmed/34943771 http://dx.doi.org/10.3390/antibiotics10121559

Ejemplares similares

Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic Analysis
por: Beraldi-Magalhaes, Francisco, et al.
Publicado: (2023)

Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
por: Mukherjee, Aparna, et al.
Publicado: (2015)

Population pharmacokinetics of ethambutol in African children: a pooled analysis
por: Tikiso, Tjokosela, et al.
Publicado: (2022)

Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol
por: Mlotha, R., et al.
Publicado: (2015)

Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study
por: Moes, Dirk Jan A. R., et al.
Publicado: (2021)

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
por: Denti, Paolo, et al.
Publicado: (2015)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
por: Ghim, Jong-Lyul, et al.
Publicado: (2019)

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
por: Westerdijk, Kim, et al.
Publicado: (2020)

Isoniazid- and ethambutol-induced psychosis
por: R., Prasad, et al.
Publicado: (2008)

Pharmacokinetic data on high dose baclofen administration in unhealthy alcohol user in the ICU
por: Vourc'h, Mickael, et al.
Publicado: (2019)

Effect of High-Dose Vitamin D on Duration of Mechanical Ventilation in ICU Patients
por: Miri, MirMohammad, et al.
Publicado: (2019)

A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants
por: Li, Haiyan, et al.
Publicado: (2020)

The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol
por: Tanner, Trevor, et al.
Publicado: (2010)

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis
por: Paccaly, Anne J., et al.
Publicado: (2021)

From Scylla to Charybdis: Fixed drug combinations for tuberculosis and increased ethambutol-induced optic neuropathy in India
por: Bhargava, Archana, et al.
Publicado: (2022)

Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy
por: Saxena, Rohit, et al.
Publicado: (2021)

Hypersensitivity Reaction and Tolerance Induction to Ethambutol
por: Cernadas, Josefina Rodrigues, et al.
Publicado: (2013)

Delayed and reversible ethambutol optic neuropathy
por: Peterson, Elizabeth, et al.
Publicado: (2022)

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2014)

Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults
por: Choi, Suein, et al.
Publicado: (2018)

Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review
por: Matsumoto, Takeshi, et al.
Publicado: (2020)

Comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy
por: Panigrahi, Pradeep K
Publicado: (2022)

Diagnosis and prognosis of COVID-19 employing analysis of patients' plasma and serum via LC-MS and machine learning
por: de Fátima Cobre, Alexandre, et al.
Publicado: (2022)

Diagnosis and prediction of COVID-19 severity: can biochemical tests and machine learning be used as prognostic indicators?
por: Cobre, Alexandre de Fátima, et al.
Publicado: (2021)

Fixed Dose Versus Loose Dose: Analgesic Combinations
por: Pergolizzi, Joseph, et al.
Publicado: (2023)

Response to comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy
por: Saxena, Rohit, et al.
Publicado: (2022)

Treating More with Less: Effectiveness and Event Outcomes of Antituberculosis Fixed-dose Combination Drug versus Separate-drug Formulation (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide) for Pulmonary Tuberculosis Patients in Real-world Clinical Practice
por: Lai, Jacqueline Mui Lan, et al.
Publicado: (2019)

Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration
por: Atkinson, Hartley C., et al.
Publicado: (2015)

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin
por: Sahasrabudhe, Vaishali, et al.
Publicado: (2018)

Erratum: Population Pharmacokinetic Analysis of Metformin Administered as Fixed-Dose Combination in Korean Healthy Adults
por: Choi, Suein, et al.
Publicado: (2018)

2554. What’s Weight Got to Do with It? Prospective Pharmacokinetic/Pharmacodynamic Evaluation of Fixed-Dose Daptomycin
por: Olney, Katie B, et al.
Publicado: (2023)

Simultaneous Quantification of Antidiabetic Agents in Human Plasma by a UPLC–QToF-MS Method
por: Fachi, Mariana Millan, et al.
Publicado: (2016)

Ocular toxicity with ethambutol therapy: Timely recaution
por: Koul, Parvaiz A
Publicado: (2015)

Mitochondrial Mutations in Ethambutol-Induced Optic Neuropathy
por: Zhang, Xiao-Hui, et al.
Publicado: (2021)

Lag times in the publication of network meta-analyses: a survey
por: Tonin, Fernanda S, et al.
Publicado: (2021)

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO(®) (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
por: Choi, YoonJung, et al.
Publicado: (2015)

Use of a Population Pharmacokinetic Approach for the Clinical Development of a Fixed-Dose Subcutaneous Formulation of Trastuzumab
por: Hourcade-Potelleret, F, et al.
Publicado: (2014)

Pharmacokinetic study of metformin to compare a voglibose/metformin fixed-dose combination with coadministered voglibose and metformin
por: Choi, Hyang-Ki, et al.
Publicado: (2015)

Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed‐Dose Combination in Healthy Adults
por: Dudkowski, Caroline, et al.
Publicado: (2016)

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers
por: Muñoz, Jose, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u8qdi6phl3ensq5735au0q4acs